BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 23547785)

  • 21. The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors.
    Van den Steen PE; Van Aelst I; Hvidberg V; Piccard H; Fiten P; Jacobsen C; Moestrup SK; Fry S; Royle L; Wormald MR; Wallis R; Rudd PM; Dwek RA; Opdenakker G
    J Biol Chem; 2006 Jul; 281(27):18626-37. PubMed ID: 16672230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor.
    Higashi S; Miyazaki K
    J Biol Chem; 2008 Apr; 283(15):10068-78. PubMed ID: 18238779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the hemopexin domain of matrix metalloproteinases in cell migration.
    Dufour A; Sampson NS; Zucker S; Cao J
    J Cell Physiol; 2008 Dec; 217(3):643-51. PubMed ID: 18636552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.
    Tochowicz A; Maskos K; Huber R; Oltenfreiter R; Dive V; Yiotakis A; Zanda M; Pourmotabbed T; Bode W; Goettig P
    J Mol Biol; 2007 Aug; 371(4):989-1006. PubMed ID: 17599356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates.
    Makowski GS; Ramsby ML
    Clin Chim Acta; 2005 Aug; 358(1-2):182-91. PubMed ID: 15921672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
    Stack MS; Itoh Y; Young TN; Nagase H
    Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
    Roeb E; Schleinkofer K; Kernebeck T; Pötsch S; Jansen B; Behrmann I; Matern S; Grötzinger J
    J Biol Chem; 2002 Dec; 277(52):50326-32. PubMed ID: 12384502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
    Nie J; Pei D
    Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
    Boon L; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Colau D; Gordon-Alonso M; van der Bruggen P; Stöcker W; Becker-Pauly C; Witters P; Morava E; Jaeken J; Proost P; Opdenakker G
    FEBS J; 2019 Mar; 286(5):930-945. PubMed ID: 30422384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R; Toth M; Peña D; Mobashery S
    Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gelatinase B deficiency protects against endotoxin shock.
    Dubois B; Starckx S; Pagenstecher A; Oord Jv; Arnold B; Opdenakker G
    Eur J Immunol; 2002 Aug; 32(8):2163-71. PubMed ID: 12209628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinase-9 in lung remodeling.
    Atkinson JJ; Senior RM
    Am J Respir Cell Mol Biol; 2003 Jan; 28(1):12-24. PubMed ID: 12495928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network.
    Kang T; Nagase H; Pei D
    Cancer Res; 2002 Feb; 62(3):675-81. PubMed ID: 11830519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin.
    Yakubenko VP; Lobb RR; Plow EF; Ugarova TP
    Exp Cell Res; 2000 Oct; 260(1):73-84. PubMed ID: 11010812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies.
    Das S; Amin SA; Jha T
    Eur J Med Chem; 2021 Nov; 223():113623. PubMed ID: 34157437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomolecular basis of matrix metallo proteinase-9 activity.
    Swetha R; Gayen C; Kumar D; Singh TD; Modi G; Singh SK
    Future Med Chem; 2018 May; 10(9):1093-1112. PubMed ID: 29676173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
    Rudra DS; Pal U; Maiti NC; Reiter RJ; Swarnakar S
    J Pineal Res; 2013 May; 54(4):398-405. PubMed ID: 23330737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
    Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
    Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
    Shoari A; Rasaee MJ; Kanavi MR; Daraei B
    J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.